Vitor Luiz da Silva

Vitor Luiz da Silva

Auto-generated profile, based on publicly available information

Vitor Luiz da Silva

Department of Biochemistry, Institute of Chemistry, University of São Paulo (USP), São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
BABryan Etindi Abuchery
Bryan Etindi Abuchery
TTThaise L. Teixeira
Thaise L. Teixeira
VSVitor L. da Silva
Vitor L. da Silva
RMRauni B. Marques
Rauni B. Marques
FGFernanda M. Gerolamo
Fernanda M. Gerolamo
Marcelo Santos da SilvaMarcelo Santos da Silva
Marcelo Santos da Silva
Trypanosoma cruzi is the etiological agent of Chagas disease (CD). During its life cycle, T. cruzi undergoes several key differentiation processes that are essential for its survival. The precise mechanisms that regulate these processes remain elusive, and any interference in this cycle would represent a breakthrough in the development of effective therapy against CD. Here we show that key differentiation processes of T. cruzi (metacyclogenesis, amastigogenesis and trypomastigogenesis) are profoundly impaired in response to low inositol hexakisphosphate kinase (IP6K) levels. Epimastigote forms of IP6K-deficient T. cruzi exhibit morphological alterations and reduced metacyclogenesis. IP6K-deficient metacyclic forms show reduced infective potential in human cardiomyocytes. IP6K-deficient amastigote forms present impaired ability to transform into trypomastigotes, with most of the population egressing from human cardiomyocytes without completing trypomastigogenesis. Although IP6K catalyzes the formation of inositol pyrophosphates (IP7), the levels of this metabolite do not undergo significant reduction in response to low IP6K levels, suggesting that this kinase sustains the T. cruzi life cycle through non-canonical functions. Since total depletion of IP6K is lethal and the primary structure of IP6K shares only ~25% similarity with its human homolog, this kinase emerges as a promising target for drug development against CD.

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CCC.M.C. Catta-Preta
C.M.C. Catta-Preta
VSV.L. Da Silva
V.L. Da Silva
CMC. Meneses
C. Meneses
KGK. Ghosh
K. Ghosh
DSDavid Sacks
David Sacks
Summary: Genetic exchange in Leishmania is established, yet the molecular mechanisms enabling hybrid formation in sand flies remain poorly defined. In Leishmania , as in plants and several protists, two paralogs of the conserved meiotic endonuclease SPO11 are present, but their contribution to hybridization is unknown. Here, we dissect the roles of SPO11-1 and SPO11-2 during in vivo sand fly infections using targeted gene deletions, catalytically-dead mutants, expression analyses, and genome-wide characterization of hybrid progeny. We show that both SPO11 paralogs are essential for efficient hybridization: deletion of either paralog in both parents abolishes hybrid recovery, and catalytic inactivation fails to rescue mating. When only one parent lacks SPO11-1 or SPO11-2, hybrid formation is reduced in a strain-dependent manner, revealing asymmetric requirements for each paralog. Genomic analysis of hybrids from SPO11-deficient crosses reveals polyploidy and altered parental genome contributions, including unbalanced and near-balanced triploid configurations, indicating disrupted reductional processes. Together, these results establish SPO11-dependent DNA break formation as a core requirement for Leishmania hybridization and define distinct, strain-specific roles for the two SPO11 paralogs. Highlights: □ Leishmania encodes two non-redundant SPO11 paralogs that are differentially required in each mating partner for efficient hybridization. □ The catalytic activity of SPO11 is essential, indicating conservation of its ancestral mode of action. □ Loss of either paralog disrupts reductional division and prevents balanced genome segregation. □ Cell fusion proceeds without SPO11 , revealing a separation between fusion and meiosis-like functions. □ SPO11 -deficient hybrids show widespread aneuploidy and highly distorted parental genome contributions.

21 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BABryan Etindi Abuchery
Bryan Etindi Abuchery
TTThaise Lara Teixeira
Thaise Lara Teixeira
VSVitor Luiz da Silva
Vitor Luiz da Silva
RMRauni Borges Marques
Rauni Borges Marques
FGFernanda Merchiori Gerolamo
Fernanda Merchiori Gerolamo
Marcelo Santos da SilvaMarcelo Santos da Silva
Marcelo Santos da Silva
Trypanosoma cruzi is the etiological agent of Chagas disease. During its life cycle, T. cruzi undergoes several key differentiation processes that are essential for its survival. The precise mechanisms that regulate these processes remain elusive, and any interference in this cycle would represent a breakthrough in the development of effective therapy against Chagas disease. Here, after depleting a single IP6K allele of T. cruzi , we observed that key differentiation processes (metacyclogenesis, amastigogenesis and trypomastigogenesis) were profoundly impaired. Epimastigote forms of IP6K-deficient T. cruzi exhibited morphological alterations and reduced metacyclogenesis. IP6K-deficient metacyclic forms had reduced infective potential in human cardiomyocytes. IP6K-deficient amastigote forms showed impaired ability to transform into trypomastigotes, with most of the population egressing from human cardiomyocytes without completing trypomastigogenesis. Together, our results suggest that IP6K is critical to sustain the T. cruzi life cycle. Since disruption of both IP6K alleles was lethal and the primary structure of IP6K shares only ∼25% similarity with its human homolog, this kinase emerges as a promising target for drug development against Chagas disease. Graphical

3 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MOMarcos Antonio F. de Oliveira
Marcos Antonio F. de Oliveira
VSVitor L. da Silva
Vitor L. da Silva
TTThaise L. Teixeira
Thaise L. Teixeira
FGFernanda M. Gerolamo
Fernanda M. Gerolamo
TGTarcillo J. N. Gaziri
Tarcillo J. N. Gaziri
Marcelo Santos da SilvaMarcelo Santos da Silva
Marcelo Santos da Silva
The thymidine analogs 5-bromo-2′-deoxyuridine (BrdU) and 5-ethynyl-2′-deoxyuridine (EdU) are widely used to monitor DNA synthesis. Although studies have reported EdU toxicity in certain cell types, no reports to date describe genotoxic effects associated with BrdU/EdU use in trypanosomatids, etiological agents of neglected tropical diseases. This lack of studies raises two possibilities: either these nucleotides are not toxic to these parasites, or the observed genotoxicity was not relevant under the experimental conditions used. Here, we assessed the potential toxicity of BrdU and EdU across three pathogenic trypanosomatids: Trypanosoma cruzi , Trypanosoma brucei , and Leishmania major. Our findings show that EdU has greater genotoxic potential than BrdU. Nevertheless, trypanosomatids respond markedly differently to DNA alterations caused by this analog: T. cruzi cells stop replicating and accumulate in S phase, T. brucei tolerates the DNA lesions generated, while part of the L. major population appears to display an ‘altruistic’ behavior that benefits the survivors. Furthermore, in silico assays suggest that, once incorporated into DNA, the ethynyl group increases the EdU’s polarity, thereby altering DNA structure more strongly than BrdU does after the first round of DNA replication. Together, our findings suggest that using thymidine analogs in trypanosomatids should be preceded by rigorous preliminary analysis, especially when using EdU. Otherwise, the data may be biased by a BrdU/EdU-triggered DNA damage response. We believe this study may serve as an atlas to guide the initial selection of thymidine analog concentrations and exposure periods. Graphical